CapLaw
  • General Editors and Editorial Board
  • Current CapLaw Issue (PDF)
  • Privacy Statement
Newsletter
  • CapLaw Themes
  • General Editors and Editorial Board
  • Current CapLaw Issue (PDF)
  • Privacy Statement

  • CapLaw Themes
  • Newsletter
  • PDF Archive

CapLaw-2019-21

  • FinSA (FIDLEG)
  • FinIA (FINIG)
  • Insurance
  • Securities
  • Regulatory
  • Takeover
  • Derivatives
  • News, Deals & Cases
  • Events
  • Other Areas
  • Spin-off of Novartis’ Alcon Business and Listing of Alcon Shares on the SIX and the NYSE
    23 May 2019
    News, Deals & Cases

    Alcon Inc., the largest eye care device company in the world, with complementary businesses in surgical and vision care, announced its debut as an independent, publicly traded company and the completion of its separation from Novartis on 9 April 2019, the day the company’s shares began trading on the SIX Swiss Exchange and New York…


    By

    CapLaw

    Reference: CapLaw-2019-21
    Read more: Spin-off of Novartis’ Alcon Business and Listing of Alcon Shares on the SIX and the NYSE

privacy@caplaw.ch
LinkedIn

Subscribe to our newsletter!

  • Privacy Statement